Tirdzniecība Artivion Inc - AORT CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Starpība | 0.15 | ||||||||
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.030779% | ||||||||
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | -0.013666% | ||||||||
Nakts laika nodeva | 22:00 (UTC) | ||||||||
Min. tirgotais daudzums | 1 | ||||||||
Valūta | USD | ||||||||
Drošības rezerve | 20% | ||||||||
Fondu birža | United States of America | ||||||||
Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Iepriekš. aizvērt* | 13.61 |
Atvērt* | 13.37 |
Izmaiņas par 1 gadu* | -22.04% |
Dienas Diapazons* | 13.32 - 13.75 |
52 ned Diapazons | 9.64-23.43 |
Vidējais apjoms (10 dienas) | 120.81K |
Vidējais apjoms (3 mēneši) | 3.65M |
Tirgus Kapitalizācija | 565.82M |
Cenas/Peļņas Attiecība | -100.00K |
Izvietotās Akcijas | 40.33M |
Ieņēmumi | 313.79M |
EPS | -1.04 |
Dividende (Ienesīgums %) | N/A |
Beta | 1.40 |
Nākamās Peļņas Datums | Feb 16, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
---|---|---|---|---|---|---|
Feb 6, 2023 | 13.61 | -0.08 | -0.58% | 13.69 | 13.98 | 13.41 |
Feb 3, 2023 | 14.00 | 0.24 | 1.74% | 13.76 | 14.44 | 13.48 |
Feb 2, 2023 | 14.09 | 1.19 | 9.22% | 12.90 | 14.10 | 12.79 |
Feb 1, 2023 | 13.07 | 0.20 | 1.55% | 12.87 | 13.32 | 12.62 |
Jan 31, 2023 | 13.01 | 1.05 | 8.78% | 11.96 | 13.02 | 11.94 |
Jan 30, 2023 | 12.34 | 0.30 | 2.49% | 12.04 | 12.62 | 12.04 |
Jan 27, 2023 | 12.43 | 0.47 | 3.93% | 11.96 | 12.64 | 11.80 |
Jan 26, 2023 | 12.42 | 0.00 | 0.00% | 12.42 | 12.60 | 12.08 |
Jan 25, 2023 | 12.60 | 0.27 | 2.19% | 12.33 | 12.66 | 12.33 |
Jan 24, 2023 | 12.75 | 0.10 | 0.79% | 12.65 | 13.16 | 12.42 |
Jan 23, 2023 | 12.83 | 0.28 | 2.23% | 12.55 | 12.98 | 12.27 |
Jan 20, 2023 | 12.60 | 0.08 | 0.64% | 12.52 | 12.78 | 12.28 |
Jan 19, 2023 | 12.44 | 0.12 | 0.97% | 12.32 | 12.55 | 12.18 |
Jan 18, 2023 | 12.29 | -0.39 | -3.08% | 12.68 | 13.06 | 12.29 |
Jan 17, 2023 | 12.70 | 0.36 | 2.92% | 12.34 | 12.97 | 12.28 |
Jan 13, 2023 | 12.67 | 0.31 | 2.51% | 12.36 | 12.91 | 12.27 |
Jan 12, 2023 | 12.74 | 0.52 | 4.26% | 12.22 | 13.01 | 12.11 |
Jan 11, 2023 | 12.60 | 0.10 | 0.80% | 12.50 | 13.16 | 12.37 |
Jan 10, 2023 | 13.05 | 0.83 | 6.79% | 12.22 | 13.11 | 11.89 |
Jan 9, 2023 | 12.29 | 0.13 | 1.07% | 12.16 | 12.55 | 12.02 |
Artivion Inc Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Ikgadējs
- Ceturkšņa
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Kopējie ienākumi | 180.38 | 189.702 | 262.841 | 276.222 | 253.227 | 298.836 |
Ienākumi | 180.38 | 189.702 | 262.841 | 276.222 | 253.227 | 298.836 |
Cost of Revenue, Total | 61.481 | 61.06 | 89.857 | 93.209 | 85.443 | 101.322 |
Bruto Peļņa | 118.899 | 128.642 | 172.984 | 183.013 | 167.784 | 197.514 |
Kopējie Darbības Izdevumi | 158.56 | 181.732 | 253.529 | 259.18 | 250.786 | 307.116 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 91.548 | 101.211 | 122.382 | 128.061 | 121.172 | 131.358 |
Pētniecība un Attīstība | 13.446 | 19.461 | 23.098 | 22.96 | 24.207 | 35.546 |
Neparedzēti Izdevumi (Ienākumi) | -7.915 | 0 | 7.4 | 4.1 | 6.2 | 21.474 |
Darbības Izdevumi | 21.82 | 7.97 | 9.312 | 17.042 | 2.441 | -8.28 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -2.971 | -4.669 | -15.562 | -14.148 | -16.481 | -21.834 |
Citi, Neto | -0.437 | 0.26 | -0.141 | -1.25 | -3.134 | -0.636 |
Neto Ienākumi Pirms Nodokļu Nomaksas | 18.412 | 3.561 | -6.391 | 1.644 | -17.174 | -14.827 |
Neto Ienākumi Pēc Nodokļu Nomaksas | 10.778 | 3.449 | -3.078 | 1.565 | -16.682 | -14.834 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | 10.778 | 3.449 | -3.078 | 1.565 | -16.682 | -14.834 |
Neto Ienākumi | 10.778 | 3.704 | -2.84 | 1.72 | -16.682 | -14.834 |
Total Adjustments to Net Income | -0.208 | -0.063 | 0.027 | -0.012 | 0.111 | 0.094 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 10.57 | 3.386 | -3.051 | 1.553 | -16.571 | -14.74 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 10.57 | 3.641 | -2.813 | 1.708 | -16.571 | -14.74 |
Atšķaidīšanas Iestāstīšana | 0.006 | 0.002 | ||||
Atšķaidītie Neto Ienākumi | 10.576 | 3.643 | -2.813 | 1.708 | -16.571 | -14.74 |
Atšķaidītie Ienākumi par Akcijām | 32.822 | 34.163 | 36.412 | 37.86 | 37.861 | 38.983 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 0.32222 | 0.09917 | -0.08379 | 0.04102 | -0.43768 | -0.37811 |
Dividends per Share - Common Stock Primary Issue | 0 | |||||
Atšķaidītā Normalizētā Peļņa par Akciju | 0.18106 | 0.09917 | 0.04831 | 0.14411 | -0.30205 | -0.28556 |
Ārkārtas Posteņi Kopā | 0.255 | 0.238 | 0.155 | |||
Depreciation / Amortization | 10.792 | 10.85 | 13.764 | 17.416 | ||
Gain (Loss) on Sale of Assets | 15.923 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Kopējie ienākumi | 71.087 | 147.235 | 72.207 | 79.394 | 77.213 |
Ienākumi | 71.087 | 147.235 | 72.207 | 79.394 | 77.213 |
Cost of Revenue, Total | 23.249 | 48.884 | 24.418 | 28.02 | 26.494 |
Bruto Peļņa | 47.838 | 98.351 | 47.789 | 51.374 | 50.719 |
Kopējie Darbības Izdevumi | 69.641 | 144.94 | 73.443 | 88.733 | 76.051 |
Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 32.724 | 65.86 | 33.36 | 32.138 | 36.334 |
Pētniecība un Attīstība | 7.754 | 16.114 | 9.972 | 9.46 | 10.128 |
Depreciation / Amortization | 4.414 | 8.808 | 4.393 | 4.215 | 4.221 |
Neparedzēti Izdevumi (Ienākumi) | 1.5 | 5.274 | 1.3 | 14.9 | -1.126 |
Darbības Izdevumi | 1.446 | 2.295 | -1.236 | -9.339 | 1.162 |
Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -4.016 | -8.379 | -4.082 | -3.873 | -3.458 |
Citi, Neto | -1.931 | -0.6 | -2.661 | -2.875 | -0.133 |
Neto Ienākumi Pirms Nodokļu Nomaksas | -4.501 | -6.684 | 7.944 | -16.087 | -2.429 |
Neto Ienākumi Pēc Nodokļu Nomaksas | -3.138 | -5.316 | 10.582 | -20.1 | -3.389 |
Neto Ienākumi Pirms Ārkārtas Posteņiem | -3.138 | -5.316 | 10.582 | -20.1 | -3.389 |
Neto Ienākumi | -3.138 | -5.316 | 10.582 | -20.1 | -3.389 |
Total Adjustments to Net Income | 0.023 | 0.029 | -0.063 | 0.128 | 0.018 |
Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | -3.115 | -5.287 | 10.519 | -19.972 | -3.371 |
Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | -3.115 | -5.287 | 10.519 | -19.972 | -3.371 |
Atšķaidītie Neto Ienākumi | -3.115 | -5.287 | 10.519 | -19.972 | -3.371 |
Atšķaidītie Ienākumi par Akcijām | 38.738 | 41.9745 | 44.453 | 39.16 | 39.85 |
Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | -0.08041 | -0.12596 | 0.23663 | -0.51001 | -0.08459 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Atšķaidītā Normalizētā Peļņa par Akciju | -0.05524 | -0.04429 | 0.02281 | -0.26269 | -0.10296 |
Gain (Loss) on Sale of Assets | 0 | 15.923 | 0 |
- Ikgadējs
- Ceturkšņa
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 147.233 | 179.28 | 179.168 | 187.39 | 234.589 | 247.697 |
Nauda un Īstermiņa Ieguldījumi | 56.642 | 39.977 | 41.489 | 33.766 | 61.412 | 55.01 |
Nauda un Ekvivalenti | 56.642 | 39.977 | 41.489 | 33.766 | 61.412 | 55.01 |
Debitoru Parādu Kopsumma, Neto | 30.096 | 51.441 | 51.432 | 55.861 | 48.752 | 58.105 |
Accounts Receivable - Trade, Net | 27.769 | 47.525 | 47.108 | 52.94 | 45.964 | 53.019 |
Total Inventory | 26.293 | 46.684 | 45.478 | 53.071 | 73.038 | 76.971 |
Prepaid Expenses | 2.815 | 4.731 | 6.848 | 11.613 | 14.295 | 14.748 |
Other Current Assets, Total | 31.387 | 36.447 | 33.921 | 33.079 | 37.092 | 42.863 |
Total Assets | 316.14 | 589.693 | 571.091 | 605.654 | 789.404 | 793.052 |
Property/Plant/Equipment, Total - Net | 18.502 | 33.579 | 31.028 | 54.144 | 51.648 | 83.235 |
Property/Plant/Equipment, Total - Gross | 73.737 | 93.095 | 95.598 | 130.101 | 138.825 | 177.76 |
Accumulated Depreciation, Total | -55.235 | -59.516 | -64.57 | -75.957 | -87.177 | -94.525 |
Goodwill, Net | 78.294 | 188.305 | 188.781 | 186.697 | 260.061 | 250 |
Intangibles, Net | 66.641 | 179.43 | 160.081 | 157.734 | 227.057 | 201.496 |
Other Long Term Assets, Total | 5.47 | 9.099 | 12.033 | 19.689 | 16.049 | 10.624 |
Total Current Liabilities | 30.102 | 42.94 | 34.523 | 45.195 | 60.468 | 44.953 |
Accounts Payable | 5.744 | 9.767 | 7.547 | 9.796 | 9.623 | 10.395 |
Accrued Expenses | 18.675 | 25.431 | 21.234 | 28.842 | 27.046 | 27.688 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 4.562 | 1.296 | 1.889 | 1.761 | 1.809 | 2.158 |
Other Current Liabilities, Total | 1.121 | 6.446 | 3.853 | 4.796 | 21.99 | 4.712 |
Total Liabilities | 107.157 | 312.635 | 296.024 | 319.958 | 460.691 | 492.324 |
Total Long Term Debt | 67.012 | 225.092 | 221.658 | 219.986 | 295.768 | 311.867 |
Long Term Debt | 67.012 | 218.236 | 215.721 | 214.571 | 290.468 | 307.493 |
Other Liabilities, Total | 10.043 | 14.172 | 12.576 | 28.933 | 69.742 | 106.705 |
Total Equity | 208.983 | 277.058 | 275.067 | 285.696 | 328.713 | 300.728 |
Common Stock | 0.342 | 0.376 | 0.385 | 0.39 | 0.404 | 0.414 |
Additional Paid-In Capital | 187.061 | 249.935 | 260.361 | 271.782 | 316.192 | 322.874 |
Retained Earnings (Accumulated Deficit) | 34.143 | 37.609 | 34.984 | 36.704 | 20.022 | 1.975 |
Treasury Stock - Common | -12.134 | -12.719 | -14.591 | -14.591 | -14.648 | -14.648 |
Other Equity, Total | -0.429 | 1.857 | -6.072 | -8.589 | 6.743 | -9.887 |
Total Liabilities & Shareholders’ Equity | 316.14 | 589.693 | 571.091 | 605.654 | 789.404 | 793.052 |
Total Common Shares Outstanding | 32.874 | 36.231 | 36.979 | 37.534 | 38.907 | 39.91 |
Capital Lease Obligations | 6.856 | 5.937 | 5.415 | 5.3 | 4.374 | |
Deferred Income Tax | 30.431 | 27.267 | 25.844 | 34.713 | 28.799 | |
Redeemable Preferred Stock | 0 | 0 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Apgrozāmo Līdzekļu Kopsumma | 235.683 | 238.054 | 257.343 | 247.697 | 244.533 |
Nauda un Īstermiņa Ieguldījumi | 56.552 | 50.473 | 64.587 | 55.01 | 51.408 |
Nauda un Ekvivalenti | 56.552 | 50.473 | 64.587 | 55.01 | 51.408 |
Debitoru Parādu Kopsumma, Neto | 50.736 | 53.284 | 55.176 | 58.105 | 59.575 |
Accounts Receivable - Trade, Net | 48.32 | 49.672 | 49.682 | 53.019 | 54.998 |
Total Inventory | 73.375 | 76.362 | 78.319 | 76.971 | 76.208 |
Prepaid Expenses | 15.22 | 16.105 | 16.104 | 14.748 | 13.378 |
Other Current Assets, Total | 39.8 | 41.83 | 43.157 | 42.863 | 43.964 |
Total Assets | 794.832 | 810.497 | 818.654 | 793.052 | 781.856 |
Property/Plant/Equipment, Total - Net | 70.57 | 84.776 | 83.886 | 83.235 | 81.824 |
Property/Plant/Equipment, Total - Gross | 48.859 | 59.042 | 58.429 | 58.097 | 57.532 |
Accumulated Depreciation, Total | -9.786 | -10.683 | -11.516 | -12.383 | -13.167 |
Goodwill, Net | 253.95 | 255.484 | 252.441 | 250 | 247.829 |
Intangibles, Net | 218.238 | 215.84 | 207.789 | 201.496 | 196.155 |
Other Long Term Assets, Total | 16.391 | 16.343 | 17.195 | 10.624 | 11.515 |
Total Current Liabilities | 58.018 | 58.944 | 61.13 | 44.953 | 42.837 |
Accounts Payable | 8.952 | 10.773 | 9.528 | 10.395 | 9.23 |
Accrued Expenses | 24.158 | 23.919 | 27.43 | 27.688 | 24.535 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 1.752 | 2.216 | 2.177 | 2.158 | 1.622 |
Other Current Liabilities, Total | 23.156 | 22.036 | 21.995 | 4.712 | 7.45 |
Total Liabilities | 497.501 | 508.662 | 507.113 | 492.324 | 484.364 |
Total Long Term Debt | 314.988 | 312.91 | 312.373 | 311.867 | 311.388 |
Long Term Debt | 310.058 | 308.05 | 307.765 | 307.493 | 307.232 |
Capital Lease Obligations | 4.93 | 4.86 | 4.608 | 4.374 | 4.156 |
Deferred Income Tax | 29.272 | 29.583 | 27.339 | 28.799 | 26.373 |
Other Liabilities, Total | 95.223 | 107.225 | 106.271 | 106.705 | 103.766 |
Total Equity | 297.331 | 301.835 | 311.541 | 300.728 | 297.492 |
Common Stock | 0.406 | 0.407 | 0.408 | 0.414 | 0.417 |
Additional Paid-In Capital | 301.449 | 305.157 | 309.29 | 322.874 | 326.799 |
Retained Earnings (Accumulated Deficit) | 13.671 | 11.493 | 22.075 | 1.975 | -1.414 |
Treasury Stock - Common | -14.648 | -14.648 | -14.648 | -14.648 | -14.648 |
Other Equity, Total | -3.547 | -0.574 | -5.584 | -9.887 | -13.662 |
Total Liabilities & Shareholders’ Equity | 794.832 | 810.497 | 818.654 | 793.052 | 781.856 |
Total Common Shares Outstanding | 39.098 | 39.255 | 39.329 | 39.91 | 40.201 |
- Ikgadējs
- Ceturkšņa
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Neto ienākumi/Sākuma Līnija | 10.778 | 3.704 | -2.84 | 1.72 | -16.682 | -14.834 |
Nauda no Darbības | 19.719 | 10.803 | 9.881 | 15.827 | 12.369 | -2.585 |
Nauda no Darbības | 8.384 | 9.745 | 18.095 | 18.317 | 20.712 | 23.977 |
Deferred Taxes | 0.595 | -1.483 | -4.485 | -2.305 | 4.283 | -4.47 |
Bezskaidras Naudas Preces | 0.045 | 9.705 | 9.123 | 17.478 | 30.752 | 25.974 |
Cash Taxes Paid | 2.501 | 3.358 | 1.699 | 1.944 | 4.122 | 5.483 |
Samaksātie Procenti Naudā | 2.446 | 2.561 | 15.005 | 13.297 | 13.049 | 14.407 |
Izmaiņas Apgrozāmajā Kapitālā | -0.083 | -10.868 | -10.012 | -19.383 | -26.696 | -33.232 |
Nauda no Ieguldījumu Darbībām | -78.907 | -171.048 | -6.715 | -23.943 | -73.128 | 5.66 |
Kapitālie Izdevumi | -6.198 | -6.632 | -5.786 | -8.072 | -7.328 | -13.091 |
Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -72.709 | -164.416 | -0.929 | -15.871 | -65.8 | 18.751 |
Nauda no Darbībām ar Finansēšanu | 73.428 | 143.245 | -2.562 | -1.493 | 93.608 | -12.223 |
Naudas Plūsma Finansēšanas Posteņos | -1.672 | -11.054 | -1.526 | -0.728 | -1.483 | -10.98 |
Akciju Izsniegšana (Atkāpšanās), Neto | 1.506 | 1.512 | 1.754 | 2.015 | 0.437 | 1.842 |
Parādu Izsniegšana (Atkāpšanās), Neto | 73.594 | 152.787 | -2.79 | -2.78 | 94.654 | -3.085 |
Ārvalstu Valūtas Ietekme | -0.317 | 0.412 | 0.879 | 1.667 | -5.185 | 2.2 |
Neto Izmaiņas Naudā | 13.923 | -16.588 | 1.483 | -7.942 | 27.664 | -6.948 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -3.138 | -5.316 | 5.266 | -14.834 | -3.389 |
Cash From Operating Activities | -3.039 | -0.392 | -3.301 | -2.585 | -0.598 |
Cash From Operating Activities | 6.006 | 11.999 | 18.008 | 23.977 | 5.881 |
Deferred Taxes | -4.241 | -4.269 | -8.128 | -4.47 | -2.966 |
Non-Cash Items | 7.269 | 17.602 | 8.774 | 25.974 | 4.771 |
Changes in Working Capital | -8.935 | -20.408 | -27.221 | -33.232 | -4.895 |
Cash From Investing Activities | -0.81 | -7.044 | 8.472 | 5.66 | -2.708 |
Capital Expenditures | -1.502 | -7.249 | -10.524 | -13.091 | -2.239 |
Other Investing Cash Flow Items, Total | 0.692 | 0.205 | 18.996 | 18.751 | -0.469 |
Cash From Financing Activities | -2.095 | -3.737 | -3.422 | -12.223 | -0.235 |
Financing Cash Flow Items | -0.442 | -2.822 | -2.658 | -10.98 | -0.129 |
Issuance (Retirement) of Stock, Net | -0.952 | 0.49 | 1.633 | 1.842 | 0.588 |
Issuance (Retirement) of Debt, Net | -0.701 | -1.405 | -2.397 | -3.085 | -0.694 |
Foreign Exchange Effects | 1.088 | 0.242 | 1.418 | 2.2 | -0.061 |
Net Change in Cash | -4.856 | -10.931 | 3.167 | -6.948 | -3.602 |
Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 15.9131 | 6417665 | -132745 | 2022-09-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 6.7971 | 2741250 | 38684 | 2022-09-30 | LOW |
Macquarie Investment Management | Investment Advisor | 6.4321 | 2594021 | 193189 | 2022-09-30 | LOW |
Wasatch Global Investors Inc | Investment Advisor/Hedge Fund | 5.2849 | 2131384 | -628634 | 2022-09-30 | LOW |
Juniper Investment Company, LLC | Investment Advisor/Hedge Fund | 5.1845 | 2090864 | 155000 | 2022-09-30 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 4.2288 | 1705448 | 18554 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.8621 | 1557565 | -30741 | 2022-09-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 3.5775 | 1442782 | 64469 | 2022-09-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 3.4676 | 1398473 | 1092275 | 2022-09-30 | LOW |
GW&K Investment Management, LLC | Investment Advisor | 3.3637 | 1356552 | -52952 | 2022-09-30 | LOW |
Perceptive Advisors LLC | Private Equity | 2.986 | 1204229 | 274524 | 2022-09-30 | LOW |
Royce Investment Partners | Investment Advisor/Hedge Fund | 2.2855 | 921732 | 62700 | 2022-09-30 | LOW |
Millennium Management LLC | Hedge Fund | 1.7573 | 708712 | 628174 | 2022-09-30 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.6666 | 672121 | 5722 | 2022-09-30 | LOW |
Kennedy Capital Management, Inc. | Investment Advisor | 1.6159 | 651681 | -13861 | 2022-09-30 | LOW |
Mackin James Patrick | Individual Investor | 1.2314 | 496635 | 116954 | 2022-11-08 | LOW |
PENN Capital Management Company, Inc. | Investment Advisor/Hedge Fund | 1.0705 | 431737 | -178798 | 2022-09-30 | MED |
ArrowMark Colorado Holdings, LLC | Investment Advisor/Hedge Fund | 1.0522 | 424340 | 22409 | 2022-09-30 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.9405 | 379281 | 2077 | 2022-09-30 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.9107 | 367261 | -1752 | 2022-09-30 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com GroupTirgotāji
Ikmēneša aktīvie klienti
Ikmēneša ieguldījumu apjoms
Izņemts katru mēnesi
Treidinga kalkulators
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Artivion Inc Company profile
Par Artivion Inc
Artivion, Inc. (Artivion), agrāk CryoLife, Inc., ir medicīnas ierīču uzņēmums. Uzņēmums koncentrējas uz dažādu risinājumu izstrādi, kas risina sirds un asinsvadu ķirurgu problēmas, ārstējot pacientus ar aortas slimībām. Uzņēmuma četras produktu grupas ietver aortas stentus un stentu transplantātus, sirds vārstuļu protēzes, kriokonservētus sirds un asinsvadu alograftus un ķirurģiskos hermētiķus. Artivion kriokonservēti sirds un asinsvadu alotransplantātu audi palīdz atjaunot operācijas pieaugušajiem un bērniem. Uzņēmums piedāvā ķirurģiskos hermētiķus, izmantojot BioGlue produktu. Tās aortas vārstuļa ķirurģiskās nomaiņas risinājumi ietver On-X aortas sirds vārstuļus un CryoValve SG plaušu vārstuļa allogrātu Ross procedūrai. Uzņēmuma mitrālā vārstuļa risinājumi ietver Chord-X mitrālā vārstuļa remontam un On-X Mitral Heart Valve. Artivion sirds un asinsvadu palīgrisinājumi nodrošina papildu atbalstu pacienta sirds un asinsvadu ķirurģiskajām procedūrām.
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
1655 Roberts Boulevard N W
KENNESAW
GEORGIA 30144
US
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 500 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com